stop the BS Tom,under $5 they cannot hold.specially OTC.they still got 200000..very good news for longs
Amgen 'like' to `kill' Affy,but find they true match in Takeda.This is more than about money,it is prestige also.imo. Very intersting to watch. GL
we are not pumpers here,do your own research, / buy into the top and sell on higher high sometimes cause distress GL
all together including the Phase 3 / Emerald studies 1-2.. with 2606 enrolling patients, 27606 patients received Omontys,the 3 fatalitys occured the first day of the application more than suspecious,The LNL/diffusion/large number law pointed to the human failure,so it not delusive if you strongly believe,Takeda will bring Omontys back to the market sooner or later. Btw/not going to suprise me if we hear further criminal investigations regarding O. jmho.GL.
you believe somebody who short AFFY all the way down from $27 and has not covered at $0.96?
C`mon I`read this book before....
could be tax losses/he nows the buyout offer or playing Machiavelli/smoke&mirror or just simple going to vacation or false flag or ....